425 related articles for article (PubMed ID: 3496541)
1. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
Walker BD; Chakrabarti S; Moss B; Paradis TJ; Flynn T; Durno AG; Blumberg RS; Kaplan JC; Hirsch MS; Schooley RT
Nature; 1987 Jul 23-29; 328(6128):345-8. PubMed ID: 3496541
[TBL] [Abstract][Full Text] [Related]
2. Loss of T-cell cytotoxic responses in the course of HIV-1 infection.
Zerhouni B; Sanhadji K; Touraine JL
Thymus; 1997; 24(4):203-19. PubMed ID: 9493284
[TBL] [Abstract][Full Text] [Related]
3. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocytes specific for the synthetic VEINCTR peptide, a sequence found within the Fas molecule and env gp120 in the blood of HIV-1 seropositive individuals.
Moukrim Z; Achour A
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):439-44. PubMed ID: 7580839
[TBL] [Abstract][Full Text] [Related]
5. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
[TBL] [Abstract][Full Text] [Related]
6. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
Perales MA; Schwartz DH; Fabry JA; Lieberman J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):27-35. PubMed ID: 7648281
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
Langlade-Demoyen P; Ngo-Giang-Huong N; Ferchal F; Oksenhendler E
J Clin Invest; 1994 Mar; 93(3):1293-7. PubMed ID: 8132769
[TBL] [Abstract][Full Text] [Related]
8. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.
Connick E; Schlichtemeier RL; Purner MB; Schneider KM; Anderson DM; MaWhinney S; Campbell TB; Kuritzkes DR; Douglas JM; Judson FN; Schooley RT
J Infect Dis; 2001 Dec; 184(11):1465-9. PubMed ID: 11709791
[TBL] [Abstract][Full Text] [Related]
9. AIDS virus-specific cytotoxic T lymphocytes in lung disorders.
Plata F; Autran B; Martins LP; Wain-Hobson S; Raphaël M; Mayaud C; Denis M; Guillon JM; Debré P
Nature; 1987 Jul 23-29; 328(6128):348-51. PubMed ID: 3496542
[TBL] [Abstract][Full Text] [Related]
10. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection.
Fan Z; Huang XL; Zheng L; Wilson C; Borowski L; Liebmann J; Gupta P; Margolick J; Rinaldo C
J Immunol; 1997 Nov; 159(10):4973-82. PubMed ID: 9366424
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals.
Walker BD; Flexner C; Paradis TJ; Fuller TC; Hirsch MS; Schooley RT; Moss B
Science; 1988 Apr; 240(4848):64-6. PubMed ID: 2451288
[TBL] [Abstract][Full Text] [Related]
12. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.
Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A
J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
[TBL] [Abstract][Full Text] [Related]
14. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
Buseyne F; Chaix ML; Fleury B; Manigart O; Burgard M; Blanche S; Rouzioux C; Rivière Y
Virology; 1998 Oct; 250(2):316-24. PubMed ID: 9792842
[TBL] [Abstract][Full Text] [Related]
15. Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection.
Lamhamedi-Cherradi S; Culmann-Penciolelli B; Guy B; Ly TD; Goujard C; Guillet JG; Gomard E
AIDS; 1995 May; 9(5):421-6. PubMed ID: 7639966
[TBL] [Abstract][Full Text] [Related]
16. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
18. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
Letvin NL; Miller MD; Shen L; Chen ZW; Yasutomi Y
Semin Immunol; 1993 Jun; 5(3):215-23. PubMed ID: 8394161
[TBL] [Abstract][Full Text] [Related]
19. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
20. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
AIDS Vaccine Evaluation Group 022 Protocol Team
J Infect Dis; 2001 Feb; 183(4):563-70. PubMed ID: 11170981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
